Riskpilot← Back to searchSign inGet full accessØYELEGESENTERET AS
ASActiveOrg 981661168Havnegata 2, 9008 TromsøMedical specialists activities · NACE 8622Est. 20005 employees
Revenue 2024
NOK 4,3M
+21% vs 2023
EBITDA margin
-6.2%
-333% vs 2023
Equity ratio
61.1%
Financial strength
Net profit 2024
NOK -440K
-1948% vs 2023
| Revenue | NOK 4,3M | +21% |
| EBITDA | NOK -266K | -333% |
| Net profit | NOK -440K | -1948% |
| Total assets | NOK 758K | -31% |
| Equity | NOK 464K | -49% |
| Employees | 5 | — |
Legal name
ØYELEGESENTERET AS
Org number
981661168
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. mars 2000
Share capital
NOK 300 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Yte service til øyelegepraksis.
Address
Havnegata 2, 9008 Tromsø
Phone
+4777647930
Email
post@oyelegesenteret.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 314 | 1 197 | 3 316 | 3 512 | 4 264 |
| Staff expenses | −537 | −529 | −1 301 | −1 545 | −2 389 |
| EBITDA | 427 | 250 | 299 | 114 | −266 |
| Depreciation & amort. | −47 | −30 | −96 | −84 | −89 |
| EBIT | 380 | 220 | 203 | 30 | −354 |
| Net financials | −1 | 0 | −0 | 0 | 1 |
| Profit before tax | 379 | 220 | 202 | 31 | −353 |
| Tax | 83 | 48 | 45 | 7 | 86 |
| Net profit | 296 | 172 | 158 | 24 | −440 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 797 | 1 053 | 1 298 | 1 105 | 758 |
| Equity | 550 | 722 | 880 | 903 | 464 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 247 | 331 | 418 | 202 | 295 |
| Total debt | 247 | 331 | 418 | 202 | 295 |
EBITDA margin
-6.2%
This company
15.8%
Market median
-139% vs market
20202024
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20202024
Return on equity
-94.8%
This company
18.4%
Market median
-615% vs market
20202024
Net profit margin
-10.3%
This company
8.1%
Market median
-227% vs market
20202024
Asset turnover
5.62×
This company
1.12×
Market median
+402% vs market
20202024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyelege Filip Stojanovic As
ØYELEGESENTERET AS Board members of ØYELEGESENTERET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amalie Steen Rosten | Chief Executive Officer | 0 companies |
| Aleksandar Stojanovic | Chairman | 0 companies |
| Erik Widerøe | Board of Directors | 0 companies |
| Anne Maddji Heatta | Chairman | 0 companies |
| Filip Stojanovic | Board of Directors | 0 companies |